SLRX icon

Salarius Pharmaceuticals

18 hedge funds and large institutions have $607K invested in Salarius Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.

Holders
18
Holders Change
+3
Holders Change %
+20%
% of All Funds
0.36%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
3
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
WVP
1
Worth Venture Partners
New Jersey
$218K 258,249
KC
2
Kepos Capital
New York
$105K 125,000 +125,000 New
DWA
3
Douglass Winthrop Advisors
New York
$67K 78,806
TRCT
4
Tower Research Capital (TRC)
New York
$44K 52,619 +52,619 New
Bank of New York Mellon
5
Bank of New York Mellon
New York
$38K 45,007 -180 -0.4%
LNWWM
6
Laird Norton Wetherby Wealth Management
California
$34K 39,746
Vanguard Group
7
Vanguard Group
Pennsylvania
$32K 38,476 +38,476 New
Northern Trust
8
Northern Trust
Illinois
$19K 22,129 +9,341 +73%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$15K 18,330
FAIM
10
Financial Advocates Investment Management
Washington
$10K 11,472
Two Sigma Investments
11
Two Sigma Investments
New York
$10K 11,621 +11,621 New
Squarepoint
12
Squarepoint
New York
$10K 11,748 +11,748 New
Osaic Holdings
13
Osaic Holdings
Arizona
$2K 2,696 +1,748 +184%
Morgan Stanley
14
Morgan Stanley
New York
$1K 1,598 -8,802 -85%
BlackRock
15
BlackRock
New York
$1K 1,197
VFA
16
Valeo Financial Advisors
Indiana
$1K 1,442
Millennium Management
17
Millennium Management
New York
$23 27,163 +27,163 New
RWB
18
RMR Wealth Builders
New Jersey
-3,000 Closed
Deutsche Bank
19
Deutsche Bank
Germany
-1,630 Closed
Bank of America
20
Bank of America
North Carolina
-13 Closed
CFGS
21
Concourse Financial Group Securities
Alabama
Wells Fargo
22
Wells Fargo
California
$0 98 +20 +26%